NCT03478878View on ClinicalTrials.gov

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 14, 2018

Primary Completion Date

June 17, 2022

Study Completion Date

June 17, 2022

Conditions
Reticular Pseudodrusen (RPD)Age-Related Macular Degeneration
Interventions
DRUG

Vitamin A Palmitate

Provide vitamin A to participants with pre/post assessments of vision.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT03478878 - Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation | Biotech Hunter | Biotech Hunter